Zobrazeno 1 - 5
of 5
pro vyhledávání: '"GholamReza Hashemitabar"'
Autor:
Mahboubeh Ebrahimian, Maryam Hashemi, Mohsen Maleki, Gholamreza Hashemitabar, Khalil Abnous, Mohammad Ramezani, Alireza Haghparast
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
Strategies to design delivery vehicles are critical in modern vaccine-adjuvant development. Nanoparticles (NPs) encapsulating antigen(s) and adjuvant(s) are promising vehicles to deliver antigen(s) and adjuvant(s) to antigen-presenting cells (APCs),
Externí odkaz:
https://doaj.org/article/a07996d07c6a481abc74656e8583086e
Publikováno v:
Tropical Animal Health and Production. 52:3501-3508
Escherichia coli (E.coli) is a normal intestinal microflora of birds, including ostrich. However, some strains are pathogenic to ostrich. There is a lack of knowledge concerning the differences between commensal and pathogenic E.coli isolates of ostr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a0853ce619f703a3723e52cb2db3d7d
https://doi.org/10.1007/s11250-020-02384-6
https://doi.org/10.1007/s11250-020-02384-6
Autor:
Fatemeh, Aflakian, Mehrnaz, Rad, Gholamreza, Hashemitabar, Milad, Lagzian, Mohammad, Ramezani
Publikováno v:
Biofouling. 38(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::86eb7791405101413def9e284b578ec3
https://pubmed.ncbi.nlm.nih.gov/35067121
https://pubmed.ncbi.nlm.nih.gov/35067121
Autor:
Abolfazl Rafati Zomorodi, Niloufar Mohseni, Maryam Hafiz, Helia Nikoueian, GholamReza Hashemitabar, Himen Salimizand, Fatemeh Aflakian
Publikováno v:
Gene Reports. 29:101695
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6cc41ada1321933872e6c3bfdd74323f
https://doi.org/10.1016/j.genrep.2022.101695
https://doi.org/10.1016/j.genrep.2022.101695
Autor:
Mahboubeh Ebrahimian, Gholamreza Hashemitabar, Mohsen Maleki, Mohammad Ramezani, Maryam Hashemi, Khalil Abnous, Alireza Haghparast
Publikováno v:
International journal of pharmaceutics. 515(1-2)
To develop effective and safe vaccines with reduced dose of antigen and adjuvant, intelligent delivery systems are required. Many delivery systems have been developed to enhance the biological activity of cytosine-phosphorothioate-guanine oligodeoxyn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b98baa90219f3a7f519c1c03f011515
https://pubmed.ncbi.nlm.nih.gov/27989827
https://pubmed.ncbi.nlm.nih.gov/27989827